MBCC Offers Review of Burgeoning Advancements in Breast Cancer Management – Targeted Oncology
Posted: January 27, 2021 at 10:54 am
In 2020 alone, the FDA approved 6 systemic therapies for novel indications across breast cancer subtypes.1 With the continuously evolving treatment landscape for this disease, staying up-to-date with the latest changes is of paramount importance.
To assist in this endeavor, the virtual 38th Annual Miami Breast Cancer Conference(MBCC), hosted by Physicians Education Resource, LLC (PER) will feature presentations from industry thought leaders on innovations in the arena of breast cancer treatment, including topics about systemic therapy and beyond.
It includes both the new data in surgery and radiation oncology [as well as that] in medical oncology, in both early-stage and metastatic disease, Hope S. Rugo, MD, FASCO, one of the program cochairs, said in an interview with Targeted Therapies in Oncology. We cover all of the clinically pertinent information thats come out of the most recent presentations and publications, and theres the ability to discuss this and ask questions of the presenters.
One of the great advantages of the meeting is its juxtaposition to the San Antonio Breast Cancer Symposium (SABCS). The virtual MBCC follows SABCS by approximately 12 weeks, March 4-7, 2021, giving MBCC faculty the advantage of tailoring the program to the most relevant research updates.
We can update the agenda to reflect the most recent data that were presented at San Antonio and apply this to the clinic, Rugo, a professor of medicine and director of Breast Oncology and Clinical Trials Education at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, said.
Rugo detailed abstracts from SABCS in which the validity of standard treatment approaches for hormone receptorpositive disease was tested in more precise patient subpopulations, with the goal of identifying those who derive the greatest benefit.
RxPONDER in Pre/Postmenopausal Patients
The randomized, phase 3 RxPONDER trial (NCT01272037) evaluated the efficacy of standard adjuvant endocrine therapy with or without chemotherapy in patients with hormone receptorpositive, HER2-negative early-stage breast cancer who had 1 to 3 positive nodes and a recurrence score of 25 or less by Oncotype DX screening.2
Results of the study demonstrated that postmenopausal women did not derive further benefit from the addition of chemotherapy, but premenopausal women with the same characteristics experienced a significant relative risk reduction in invasive diseasefree survival (iDFS).
Using the recurrence score is fascinating and will result in a lot more analyses, Rugo said. This already will impact our care of patients with node-positive, early-stage hormone receptorpositive, HER2-negative breast cancer.
Despite no significant difference in iDFS noted with or without chemotherapy in the primary analysis (P=.3), a prespecified subgroup analysis revealed that an interaction between chemotherapy use and menopausal status existed (P=.004). The hazard ratio for the comparison of both treatment arms favored the use of chemotherapy in patients who were premenopausal (HR, 0.54; 95% CI, 0.38-0.76; P =.0004) versus those who were postmenopausal (HR, 0.97; 95% CI 0.78-1.22; P =.82). At 5 years, the iDFS rate in the premenopausal group was 94.2% for those who received versus 89.0% in those who did not.
Results of a subanalysis of the randomized phase 3 monarchE trial (NCT03155997) of adjuvant endocrine therapy with or without abemaciclib (Verzenio) in patients with resectable hormone receptorpositive, HER2-negative tumors at high risk suggest that a threshold of 20% or greater Ki-67, which is a marker of cellular proliferation, may be a useful clinicopathological feature of response to the CDK4/6 inhibitor.3
Its not just the clinical features, like stage and grade, but Ki-67 also is emerging as an incredibly important factor, Rugo said of the results, which were also reported at SABCS. I think this is likely to be practice changing in the next year.
Patients with high Ki-67 in the overall patient population and patients in cohort 1those with other high-risk clinicopathological features such as tumor involvement, tumor size, and gradewere assessed for superiority of abemaciclib therapy as determined by iDFS. A statistically significant improvement in the primary end point was seen with the agent in both the overall population (HR, 0.685; 95% CI, 0.462-1.017; P=.0591) and in cohort 1 (HR, 0.643;95% CI, 0.475-0.872; 2-sided P=.0042).
J101 Reveals HER2-Low Populations
The phase 1 J101 trial (NCT02564900) of fam-trastuzumab deruxtecan-nxki (Enhertu) indicated that certain patients with low HER2 expression, defined as those with an immunohistochemistry (IHC) score of 2+/1+ and negativity by in situ hybridization, may derive benefit from treatment with the antibody-drug conjugate. These data, which were also presented at SABCS, may help potentially define a patient population of medical unmet need who would otherwise not be treated with anti-HER2 therapy.4
Were going to see data in the next year about the efficacy of these antibody-drug conjugates in other populations, such as patients who have newly-defined HER2-low disease, Rugo said. [These patients are] not HER2 positive but not 0 by IHC.
Patients in the analysis were assessed using deep learningbased digital analysis to produce a novel HER2 quantitative continuous score (QCS), a method found to be more predictive of response to trastuzumab deruxtecan versus manual assessment by pathologists.
Out of 151 patients, 65 were identified as having HER2-low expression by conventional IHC scoring; the response rate in this group was 42%. When investigators further stratified the patients into QCS-high and QCS-low subgroups, they were able to identify 21 of the 27 responders who were missed by conventional screening methods. To validate these promising results, further studies into the use of QCS are ongoing.
Rugo said several immunotherapy agents could possibly become available for use in the adjuvant/neoadjuvant setting in the near future, mirroring the success seen in advanced tumors.
Namely, results of one investigational arm of the open-label, randomized, phase 2 I-SPY 2platform study that were published in JAMA Oncology in February 2020 showed that the addition of pembrolizumab (Keytruda) to standard neoadjuvant chemotherapy more than doubled pathologic complete response rates in patients with hormone receptorpositive/HER2-negative and triple-negative breast cancer.5 Further exploration of this data set examined surrogate markers of this regimen and were presented at SABCS.6 Larger studies are ongoing.
I think the analyses of immunotherapy in the metastatic setting are already practice changing and in the next year will potentially be practice changing for the neoadjuvant setting as well, Rugo said.
Other agents to watch for are antibody-drug conjugates, such as trastuzumab deruxtecan and sacituzumab govitecanhziy (Trodelvy), as therapy for patients with triple-negative breast cancer. Rugo said data from trials involving these agents are likely to be reported this year and have the potential to change the treatment paradigm for triple-negative disease.
To conclude, Rugo reflected on the advantages of MBCC for those treating patients with breast cancer across clinical settings. You will get that great interaction with the speakers and timely updates of [the latest] data put into perspective.
References:
1. Hematology/oncology (cancer) approvals & safety notifications. FDA. Updated December 18, 2020. Accessed December 21, 2020. https://bit.ly/3avuIwR
2. Kalinsky K, Barlow WE, Meric-Bernstam F, et al. First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder). Presented at: 2020 San Antonio Breast Cancer Symposium; December 8-12, 2020; virtual. Abstract GS3-0 . https://bit.ly/2WsISGT
3. Harbeck N, Johnston S, Fasching P, et al. High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE. Presented at: 2020 San Antonio Breast Cancer Symposium; December 8-12, 2020; virtual. https://bit.ly/2WsISGT
4. Gustavson M, Hanedar S, Spitzmeuller A, et al. Novel approach to HER2 quantification: digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients. Presented at: 2020 San Antonio Breast Cancer Symposium; December 8-12, 2020; virtual. https://bit.ly/2WsISGT
5. Nanda R, Liu MC, Yau C, et al. Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: an analysis of the ongoing phase 2 adaptively randomized I-SPY2 trial. JAMA Oncol. 2020;6(5):676-684. doi:10.1001/jamaoncol.2019.6650
6. Magbanua MJM, Wolf D, Renner D, et al. Personalized ctDNA as a predictive biomarker in high-risk early stage breast cancer (EBC) treated with neoadjuvant chemotherapy (NAC) with or without pembrolizumab (P). Presented at: 2020 San Antonio Breast Cancer Symposium; December 8-12, 2020; virtual. https://bit.ly/2WsISGT
Read the original post:
MBCC Offers Review of Burgeoning Advancements in Breast Cancer Management - Targeted Oncology
- Hormone therapy: Is it right for you? - Mayo Clinic [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- LifeXmd :: Bioidentical Hormone Replacement Therapy Center [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Bioidentical hormones: Are they safer? - Mayo Clinic [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Diabetes and Hormone Center of the Pacific [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hormone Replacement Clinic | Topeka & Lawrence KS [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Integrative Health and Hormone Clinic Cedar Rapids, IA [Last Updated On: May 31st, 2015] [Originally Added On: May 31st, 2015]
- Hormone Center - Home [Last Updated On: May 31st, 2015] [Originally Added On: May 31st, 2015]
- How Are Hormones And Anxiety Related? - Calm Clinic [Last Updated On: June 13th, 2015] [Originally Added On: June 13th, 2015]
- Women's Mood & Hormone Clinic / Moms Program | UCSF ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Dallas Anti Aging Clinic for Men | Male Hormone ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Hormone clinic to open - News Sentinel Story [Last Updated On: July 10th, 2015] [Originally Added On: July 10th, 2015]
- Male Hormone Replacement - Testosterone - The Turek Clinic [Last Updated On: August 1st, 2015] [Originally Added On: August 1st, 2015]
- Bio-Identical Hormones & Women's Services at Dr. Wright's ... [Last Updated On: August 21st, 2015] [Originally Added On: August 21st, 2015]
- HGH Therapy | HGH Clinics | Human Growth Hormone Therapy [Last Updated On: August 24th, 2015] [Originally Added On: August 24th, 2015]
- Long Island Hormone Therapy Clinic NY, Anti-Aging Clinics ... [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Home - Seattle Hormone Replacement Clinic for Men [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Medical Weight Loss Clinic of Utah - Hormone Replacement ... [Last Updated On: September 29th, 2015] [Originally Added On: September 29th, 2015]
- What are Hormones? - Hormone Replacement Therapy Denver [Last Updated On: October 4th, 2015] [Originally Added On: October 4th, 2015]
- Human growth hormone (HGH): Does it slow aging? - Mayo Clinic [Last Updated On: October 9th, 2015] [Originally Added On: October 9th, 2015]
- Bioidentical Hormone Replacement Therapy - Amen Clinics [Last Updated On: October 12th, 2015] [Originally Added On: October 12th, 2015]
- HD Medspa & Clinic | Lakeview Neighborhood, Chicago, for ... [Last Updated On: October 18th, 2015] [Originally Added On: October 18th, 2015]
- Denver Hormone Therapy | Denver Hormone Health [Last Updated On: April 8th, 2016] [Originally Added On: April 8th, 2016]
- Bioidentical Hormone Replacement Therapy for Men and Women ... [Last Updated On: April 29th, 2016] [Originally Added On: April 29th, 2016]
- The Endocrine Clinic | Singapore Hormone Specialists [Last Updated On: June 5th, 2016] [Originally Added On: June 5th, 2016]
- San Antonio Natural Hormone Therapy Clinic | Bio-Identical ... [Last Updated On: June 16th, 2016] [Originally Added On: June 16th, 2016]
- Does hormone replacement medication ... - Lindora Clinic [Last Updated On: June 30th, 2016] [Originally Added On: June 30th, 2016]
- FEMME CLINIQUE - Bio-Identical Hormone Therapy Clinic ... [Last Updated On: June 30th, 2016] [Originally Added On: June 30th, 2016]
- Dr Colin Holloway | Managing hormone imbalances [Last Updated On: July 2nd, 2016] [Originally Added On: July 2nd, 2016]
- melatonin hormone - University of Maryland Medical Center [Last Updated On: July 7th, 2016] [Originally Added On: July 7th, 2016]
- Human chorionic gonadotropin - Wikipedia, the free ... [Last Updated On: July 20th, 2016] [Originally Added On: July 20th, 2016]
- Talk to Nurse Rita - Health, Nursing & Clinic Matters [Last Updated On: July 24th, 2016] [Originally Added On: July 24th, 2016]
- NATESTO (testosterone) Nasal Gel CIII | Prescriber Site [Last Updated On: August 24th, 2016] [Originally Added On: August 24th, 2016]
- Home : Cleveland Clinic Journal of Medicine [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
- Ageing - Wikipedia, the free encyclopedia [Last Updated On: September 21st, 2016] [Originally Added On: September 21st, 2016]
- Melatonin - Wikipedia, the free encyclopedia [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Hormone Replacement Clinic in NJ | Healthy Aging Medical ... [Last Updated On: October 11th, 2016] [Originally Added On: October 11th, 2016]
- UT Southwestern, Dallas, Texas - UTSW Medicine (Patient ... [Last Updated On: October 15th, 2016] [Originally Added On: October 15th, 2016]
- Clinical Guidelines and Recommendations | Agency for ... [Last Updated On: November 15th, 2016] [Originally Added On: November 15th, 2016]
- Hormone Replacement Therapy | Born Clinic [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- Medical Weight Loss | Endocrinology & Hormone Replacement [Last Updated On: November 25th, 2016] [Originally Added On: November 25th, 2016]
- West Coast Womens Clinic - Vancouver Womens Health Clinic [Last Updated On: November 28th, 2016] [Originally Added On: November 28th, 2016]
- Prolactin - Wikipedia [Last Updated On: December 11th, 2016] [Originally Added On: December 11th, 2016]
- Worrying about Anti Mullerian Hormones? | Baby Hopeful [Last Updated On: December 19th, 2016] [Originally Added On: December 19th, 2016]
- Risk of Pregnancy Loss in Subclinical Hypothyroidism - Endocrinology Advisor [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Public invited to women's clinic opening in New Albany - Evening News and Tribune [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Thyroid Hormone Therapy for Subclinical Hypothyroidism in Pregnancy - Medical News Bulletin [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Transgender youth in Alberta need more than 1 part-time clinic, says new campaign - CBC.ca [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- BRUCKNER: UNL a national model for trans, LGBT care - Daily Nebraskan [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Hospital in Somerset becomes first in NJ to open LGBTQ health center - New Jersey 101.5 FM Radio [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Four NIH-backed projects aim to advance the artificial pancreas - MobiHealthNews [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- In Transition: Physical transitions can include hormone treatment, surgery - The Baylor Lariat [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Amphetamine use may 'speed up' heart aging - Medical News Today [Last Updated On: February 11th, 2017] [Originally Added On: February 11th, 2017]
- Nationwide Planned Parenthood protests energize patients, opponents - SFGate [Last Updated On: February 11th, 2017] [Originally Added On: February 11th, 2017]
- Women's wellness: Understanding hypothyroidism and pregnancy - The Killeen Daily Herald [Last Updated On: February 12th, 2017] [Originally Added On: February 12th, 2017]
- How This Police Officer Is Helping Trans Patients Get Better Care - Refinery29 [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Most cases of thyroid cancer are curable - Post-Bulletin [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Is hormone melatonin the link between sleep and breast cancer? - Knowridge Science Report [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- In West Africa, clinics confront suspicion, and husbands, one IUD at a time - STAT [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- 'Speed' and other recreational stimulants tied to heart damage - Fox News [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- Research shows balancing hormones can aid weight loss - WLS-TV [Last Updated On: February 18th, 2017] [Originally Added On: February 18th, 2017]
- These transgender patients now have a place to change their lives all at once - Miami Herald [Last Updated On: February 20th, 2017] [Originally Added On: February 20th, 2017]
- Healthy eating, the Hyman way - Durham Herald Sun [Last Updated On: February 21st, 2017] [Originally Added On: February 21st, 2017]
- Balancing hormones and weight loss - UPMatters.com [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Have You Heard of These 5 Heart Attack Risk Factors? - Health Essentials from Cleveland Clinic (blog) [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Feeling stressed? Try these proven methods for chilling out - Los Angeles Times [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Mother & Son Swap Sexes At The Same Time! - Radar Online [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- The truth about why some men get sleepy after sex | Fox News - Fox News [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- Wellness experts use hormone balancing to fight obesity - WNDU-TV [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- These transgender patients now have a place to change their lives all at once - San Angelo Standard Times [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- Obese couples may take longer to conceive - Fox News [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Even More Reason to Kick That Sedentary Lifestyle - LifeZette [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- What Happens When Your Immune System Gets Stressed Out? - Health Essentials from Cleveland Clinic (blog) [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Boutique Egg Freezing Clinics Are the Latest Trend for Those Looking to Delay Parenthood - Babble (blog) [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Municipal Hospital System Opens NYC's First Public Clinic Offering Gender-Reassignment Surgery - NY1 [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Walking has many Health Benefit - Plainview Daily Herald [Last Updated On: March 3rd, 2017] [Originally Added On: March 3rd, 2017]
- Isoflavones in food associated with reduced mortality for women with some breast cancers - Tufts Now [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Planned Parenthood New York Now Offers Transgender Hormone Replacement Therapy - The Mary Sue [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Doctor Allie International Hormone Success Doctor Joins the ... - Satellite PR News (press release) [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Hormone Therapy Clinic | Human Growth Hormone ... [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Dubai clinic offering free fertility tests for women throughout March ... - Emirates 24|7 [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]